Ignite Creation Date:
2024-05-06 @ 7:45 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06123754
Status:
RECRUITING
Last Update Posted:
2024-01-31
First Post:
2023-10-25
Brief Title:
Phase III Study of Envafolimab Versus Placebo Plus Chemotherapy in Resectable Stage III NSCLC
Sponsor:
3D Medicines Sichuan Co Ltd
Organization:
3D Medicines
Organization Data
Organization:
3D Medicines
Class:
INDUSTRY
Study ID:
KN035-CN-017
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
3D Medicines Sichuan Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None